ANALYSIS OF EXPENDITURE IN MULTIPLE SCLEROSIS DISEASE MODIFYING THERAPIES EVOLUTION BETWEEN 2004-2015 IN SPAIN
Author(s)
Villoro R1, Hidalgo A2
1Instituto Max Weber, Madrid, Spain, 2University of Castilla-La Mancha, Toledo, Spain
Presentation Documents
OBJECTIVES: To analyze factors of recent evolution of Multiple Sclerosis (MS) Disease Modifying Therapies (DMT) budgets in Spain between 2004 and 2015. METHODS:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PND31
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Neurological Disorders
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now